[Proceedings: Effect of pyridinolcarbamate on the lipid metabolism of normal and atherosclerotic intima in human femoral arteries].
D001161:Arteriosclerosis / Q000378:metabolism*; D002219:Carbamates / Q000494:pharmacology*; D005263:Femoral Artery / Q000378:metabolism*; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D011727:Pyridinolcarbamate / Q000494:pharmacology
D002219:Carbamates; D000960:Hypolipidemic Agents; D011727:Pyridinolcarbamate
Die Wirkung von Pyridinolcarbamat auf den Lipidstoffwechsel normaler und atherosklerotisch veränderter Intima in menschlichen Femoralarterien